Ocugen Statistics
Share Statistics
Ocugen has 292.03M
shares outstanding. The number of shares has increased by 13.47%
in one year.
| Shares Outstanding | 292.03M |
| Shares Change (YoY) | 13.47% |
| Shares Change (QoQ) | 0.24% |
| Owned by Institutions (%) | 24.63% |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | 26,686 |
| FTD / Avg. Volume | 0.71% |
Short Selling Information
The latest short interest is 68.23M, so 23.42% of the outstanding
shares have been sold short.
| Short Interest | 68.23M |
| Short % of Shares Out | 23.42% |
| Short % of Float | 23.82% |
| Short Ratio (days to cover) | 23.77 |
Valuation Ratios
The PE ratio is -4.04 and the forward
PE ratio is -2.78.
Ocugen's PEG ratio is
0.17.
| PE Ratio | -4.04 |
| Forward PE | -2.78 |
| PS Ratio | 53.8 |
| Forward PS | 0.3 |
| PB Ratio | 7.36 |
| P/FCF Ratio | -4.79 |
| PEG Ratio | 0.17 |
Financial Ratio HistoryEnterprise Valuation
Currently the Enterprise Value (EV) is not available for Ocugen.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.86,
with a Debt / Equity ratio of 1.1.
| Current Ratio | 2.86 |
| Quick Ratio | 2.86 |
| Debt / Equity | 1.1 |
| Debt / EBITDA | -0.62 |
| Debt / FCF | -0.71 |
| Interest Coverage | 0 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $42,684.21 |
| Profits Per Employee | $-568,989.47 |
| Employee Count | 95 |
| Asset Turnover | 0.05 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | 0% |
Stock Price Statistics
The stock price has increased by -64.29% in the
last 52 weeks. The beta is 4.23, so Ocugen's
price volatility has been higher than the market average.
| Beta | 4.23 |
| 52-Week Price Change | -64.29% |
| 50-Day Moving Average | 0.66 |
| 200-Day Moving Average | 0.88 |
| Relative Strength Index (RSI) | 49.74 |
| Average Volume (20 Days) | 3,742,828 |
Income Statement
In the last 12 months, Ocugen had revenue of 4.05M
and earned -54.05M
in profits. Earnings per share was -0.2.
| Revenue | 4.05M |
| Gross Profit | 2.09M |
| Operating Income | -54.76M |
| Net Income | -54.05M |
| EBITDA | -52.79M |
| EBIT | -54.76M |
| Earnings Per Share (EPS) | -0.2 |
Full Income StatementBalance Sheet
The company has 58.51M in cash and 32.5M in
debt, giving a net cash position of 26.01M.
| Cash & Cash Equivalents | 58.51M |
| Total Debt | 32.5M |
| Net Cash | 26.01M |
| Retained Earnings | -340.22M |
| Total Assets | 64.46M |
| Working Capital | 27.08M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -42.14M
and capital expenditures -3.38M, giving a free cash flow of -45.53M.
| Operating Cash Flow | -42.14M |
| Capital Expenditures | -3.38M |
| Free Cash Flow | -45.53M |
| FCF Per Share | -0.17 |
Full Cash Flow StatementMargins
Gross margin is 51.47%, with operating and profit margins of -1350.36% and -1333.02%.
| Gross Margin | 51.47% |
| Operating Margin | -1350.36% |
| Pretax Margin | -1333.02% |
| Profit Margin | -1333.02% |
| EBITDA Margin | -1301.82% |
| EBIT Margin | -1350.36% |
| FCF Margin | -1122.74% |
